Telix Pharmaceuticals stock forecast
Telix Pharmaceuticals (TLX1N) Stock Forecast & Price Target
TLX1N Analyst Ratings
TLX1N Stock 12 Month Forecast
Average Price Target
Mex$314.63▲(3.99% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Shane Storey | Canaccord Genuity | Mex$397.58 | buy | 31.41%Upside | Reiterated | 11/08/26 | ||
| Steven Wheen | Jarden | Mex$265.05 | buy | -12.39%Downside | Reiterated | 11/05/26 | ||
| David Low | UBS | Mex$328.16 | buy | 8.46%Upside | Reiterated | 11/04/26 | ||
| Laura Sutcliffe | Citi | Mex$391.27 | buy | 29.32%Upside | Reiterated | 11/04/26 | ||
| Ord Minnett | Mex$277.67→Mex$237.28 | buy | -21.57%Downside | Reiterated | 10/27/26 | |||
| Craig Wong-Pan | RBC Capital | Mex$265.05 | buy | -12.39%Downside | Reiterated | 10/21/26 | ||
| David Stanton | Jefferies | Mex$403.89→Mex$397.58 | buy | 31.41%Upside | Reiterated | 10/21/26 | ||
| John Hester | Bell Potter | Mex$239.81 | buy | -20.74%Downside | Reiterated | 09/21/26 | ||
| David Bailey | Morgan Stanley | Mex$301.65 | buy | -0.30%Downside | Reiterated | 09/15/26 | ||
| Chris Cooper | J.P. Morgan | Mex$322.86 | buy | 6.71%Upside | Reiterated | 09/14/26 | ||
| Tara Bancroft | TD Cowen | Mex$252.43 | buy | -16.57%Downside | Reiterated | 02/19/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Shane StoreyCanaccord Genuity | BuyReiteratedMex$397.58 | 11/08/26 | 31.41%Upside | ||
| Steven WheenJarden | BuyReiteratedMex$265.05 | 11/05/26 | -12.39%Downside | ||
| David LowUBS | BuyReiteratedMex$328.16 | 11/04/26 | 8.46%Upside | ||
| Laura SutcliffeCiti | BuyReiteratedMex$391.27 | 11/04/26 | 29.32%Upside | ||
| BuyReiteratedMex$277.67→Mex$237.28 | 10/27/26 | -21.57%Downside | |||
| Craig Wong-PanRBC Capital | BuyReiteratedMex$265.05 | 10/21/26 | -12.39%Downside | ||
| David StantonJefferies | BuyReiteratedMex$403.89→Mex$397.58 | 10/21/26 | 31.41%Upside | ||
| John HesterBell Potter | BuyReiteratedMex$239.81 | 09/21/26 | -20.74%Downside | ||
| David BaileyMorgan Stanley | BuyReiteratedMex$301.65 | 09/15/26 | -0.30%Downside | ||
| Chris CooperJ.P. Morgan | BuyReiteratedMex$322.86 | 09/14/26 | 6.71%Upside | ||
| Tara BancroftTD Cowen | BuyReiteratedMex$252.43 | 02/19/26 | -16.57%Downside |
Best Analysts Covering Telix Pharmaceuticals
Copying David Stanton's trades and holding each position for 3 Months would result in 63.64% of your transactions generating a profit, with an average return of +18.67% per trade.
Copying Steven Wheen's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +38.20% per trade.
Copying Steven Wheen's trades and holding each position for 2 Years would result in 56.67% of your transactions generating a profit, with an average return of +71.80% per trade.
TLX1N Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 14 | 15 | 22 | 19 | 19 |
| Buy | 4 | 5 | 16 | 17 | 14 |
| Hold | 2 | 3 | 4 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 20 | 23 | 42 | 38 | 34 |
In the current month, TLX1N has received 33 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. TLX1N average Analyst price target in the past 3 months is 314.63.
TLX1N Financial Forecast
TLX1N Earnings Forecast
Next quarter’s earnings estimate for TLX1N is MXN 1.12 with a range of MXN 1.12 to MXN 1.12. The previous quarter’s EPS was MXN 3.17. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
TLX1N Sales Forecast
Next quarter’s sales forecast for TLX1N is MXN 4.66B with a range of MXN 4.63B to MXN 4.68B. The previous quarter’s sales results were MXN 8.95B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

